Life Science REIT PLC (LABS) — Cash Flow Reinvestment Rate
Life Science REIT PLC (LABS) has a Cash Flow Reinvestment Rate of 6.06x as of June 2025, reinvesting GBX5.81 Million (capex GBX5.81 Million ) from operating cash flow of GBX958.00K. Explore LABS capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Life Science REIT PLC Cash Flow Reinvestment Rate (2021–2024)
Historical reinvestment intensity for Life Science REIT PLC across 3 annual periods. Also explore LABS current and non-current assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Life Science REIT PLC (2021–2024)
Year-by-year capital reinvestment analysis for Life Science REIT PLC. For live market cap and broader valuation context, see Life Science REIT PLC (LABS) total market value.
| Year | Reinvestment Rate | Total Reinvested (GBX) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 2.76x | GBX35.63 Million | GBX12.92 Million | GBX19.28 Million | ▼ -41.1% |
| 2023 | 4.69x | GBX35.68 Million | GBX7.62 Million | GBX24.03 Million | ▼ -91.2% |
| 2021 | 53.46x | GBX189.16 Million | GBX3.54 Million | GBX7.64 Million | — |